(Q42277917)

19 October 2017

TG13 antimicrobial therapy for acute cholangitis and cholecystitis (English)

1 reference

19 October 2017

0 references

ascending cholangitis

0 references

1 reference

Harumi Gomi

1

1 reference

19 October 2017

Joseph S Solomkin

2

1 reference

19 October 2017

Tadahiro Takada

3

1 reference

19 October 2017

Steven M Strasberg

4

1 reference

19 October 2017

Henry A Pitt

5

1 reference

19 October 2017

Masahiro Yoshida

6

1 reference

19 October 2017

Shinya Kusachi

7

1 reference

19 October 2017

Toshihiko Mayumi

8

1 reference

19 October 2017

Fumihiko Miura

9

1 reference

19 October 2017

Seiki Kiriyama

10

1 reference

19 October 2017

Masamichi Yokoe

11

1 reference

19 October 2017

Yasutoshi Kimura

12

1 reference

19 October 2017

Ryota Higuchi

13

1 reference

19 October 2017

John A Windsor

14

1 reference

19 October 2017

Christos Dervenis

15

1 reference

19 October 2017

Kui-Hin Liau

16

1 reference

19 October 2017

Myung-Hwan Kim

17

1 reference

19 October 2017

Tokyo Guideline Revision Committee

18

1 reference

19 October 2017

1 January 2013

1 reference

Journal of Hepato-biliary-Pancreatic Sciences

19 October 2017

1 reference

19 October 2017

20

1 reference

19 October 2017

1

1 reference

19 October 2017

60-70

1 reference

https://scigraph.springernature.com/pub.10.1007/s00534-012-0572-0

19 October 2017

0 references

cites work

Antimicrobial therapy for acute cholangitis: Tokyo Guidelines

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Antimicrobial therapy for acute cholecystitis: Tokyo Guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Surveillance of antimicrobial susceptibility of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in China: the 2002-2009 Study for Monitoring Antimicrobial Resistance Trends (SMART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Re

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Evaluation of antimicrobial susceptibility for beta-lactams using the Etest method against clinical isolates from 100 medical centers in Japan (2006).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Evaluation of antimicrobial susceptibility for β-lactams against clinical isolates from 51 medical centers in Japan (2008).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

The clinical epidemiology and outcomes of bacteremic biliary tract infections caused by antimicrobial-resistant pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Resistance in gram-negative bacteria: Enterobacteriaceae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Bacteriology of the gallbladder bile in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Simultaneous bacteriologic assessment of bile from gallbladder and common bile duct in control subjects and patients with gallstones and common duct stones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Microbiology and antibiotic susceptibility of organisms in bile cultures from patients with and without cholangitis at an Asian academic medical center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Septic acute cholecystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Biliary tract infection and bacteraemia: presentation, structural abnormalities, causative organisms and clinical outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Epidemiology and prognostic determinants of patients with bacteremic cholecystitis or cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Bacteremia -- prevalence and associated factors in patients with acute calculous cholecystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Clinical impact of blood cultures taken in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Antibiotic dosing in critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Tigecycline: a glycylcycline antimicrobial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Excess deaths associated with tigecycline after approval based on noninferiority trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Prospective randomized comparison of pefloxacin and ampicillin plus gentamicin in the treatment of bacteriologically proven biliary tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis: a randomized, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Editorial commentary: Asking the right questions: morbidity, mortality, and measuring what's important in unbiased evaluations of antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Two cases of monomicrobial intraabdominal abscesses due to KPC--3 Klebsiella pneumoniae ST258 clone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Guidelines for antibiotic prophylaxis for GI endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Prophylactic antibiotics cannot prevent endoscopic retrograde cholangiopancreatography-induced cholangitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

ERCP: Complications and prophylaxis a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Antibiotic prophylaxis for infectious complications after therapeutic endoscopic retrograde cholangiopancreatography: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Antibiotic prophylaxis using cefuroxime in bile duct endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Antibiotic prophylaxis of infectious complications with endoscopic retrograde cholangiopancreatography. A randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Post-ERCP pancreatitis: reduction by routine antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Updated recommendations for control of surgical site infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

Prevalence, microbiology, and clinical characteristics of extended-spectrum beta-lactamase-producing Enterobacter spp., Serratia marcescens, Citrobacter freundii, and Morganella morganii in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-012-0572-0

10.1007/S00534-012-0572-0

21 January 2018

Identifiers

DOI

1 reference

19 October 2017

1 reference